Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (451-460 of 480) with videos related to

Pageof 48
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2020
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and managementJohn O'Brien, John Paul Taylor, Clive Ballard, et al.
The Lancet. Psychiatry|April 19, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceEmily A Holmes, Rory C O'Connor, V Hugh Perry, et al.
Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
Lancet (London, England)|August 3, 2020
Dementia prevention, intervention, and care: 2020 report of the Lancet CommissionGill Livingston, Jonathan Huntley, Andrew Sommerlad, et al.
Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.
Brain : a Journal of Neurology|August 14, 2020
Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker ResearchCorinne E Fischer, Zahinoor Ismail, James M Youakim, et al.
The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.
BMC Public Health|November 1, 2018
Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active lifeBarbora Silarova, Sharon M Nelis, Rosalie M Ashworth, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Pageof 48

Showing results (451-460 of 480) with videos related to

Sort By:
Pageof 48
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2020
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and managementJohn O'Brien, John Paul Taylor, Clive Ballard, et al.
The Lancet. Psychiatry|April 19, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceEmily A Holmes, Rory C O'Connor, V Hugh Perry, et al.
Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
Lancet (London, England)|August 3, 2020
Dementia prevention, intervention, and care: 2020 report of the Lancet CommissionGill Livingston, Jonathan Huntley, Andrew Sommerlad, et al.
Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.
Brain : a Journal of Neurology|August 14, 2020
Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker ResearchCorinne E Fischer, Zahinoor Ismail, James M Youakim, et al.
The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.
BMC Public Health|November 1, 2018
Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active lifeBarbora Silarova, Sharon M Nelis, Rosalie M Ashworth, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Pageof 48